✦ LIBER ✦

Taxane vs. taxane: is the duel at an end? A commentary on a phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study

✍ Scribed by Sofyan M. Radaideh; George W. Sledge

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 174 KB
Volume: 111
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9776-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase-III trial of doxorubicin and doc

A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study

✍ Philippe A. Cassier; Sylvie Chabaud; Véronique Trillet-Lenoir; Pierre-Yves Peaud 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 233 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views